09/07/2026
365 injections a year... reduced to just 52! 💉
A breakthrough in diabetes care has arrived in India. Could this once-a-week insulin change millions of lives? Read the full story and share your thoughts.
Novo Nordisk has launched Awiqli, the world's first once-weekly basal insulin, in India for adults with Type 1 and Type 2 diabetes. The new therapy can reduce insulin injections from 365 to just 52 a year, potentially improving treatment adherence. Priced at around ₹2,600 per pen, the company says it aims to ease the psychological and physical burden of daily insulin use in a country with over 101 million people living with diabetes.
Image Credit: News18